# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098534
Filing Date
2024-11-14
Accepted
2024-11-14 16:57:46
Documents
50
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0217946-10q_actinium.htm iXBRL | 10-Q | 783663
2 | CERTIFICATION | ea021794601ex31-1_actinium.htm | EX-31.1 | 10498
3 | CERTIFICATION | ea021794601ex31-2_actinium.htm | EX-31.2 | 9832
4 | CERTIFICATION | ea021794601ex32-1_actinium.htm | EX-32.1 | 4188
5 | CERTIFICATION | ea021794601ex32-2_actinium.htm | EX-32.2 | 4427
6 | GRAPHIC | image_001.jpg | GRAPHIC | 90357
| Complete submission text file | 0001213900-24-098534.txt |  | 3851275

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | atnm-20240930.xsd | EX-101.SCH | 27350
8 | XBRL CALCULATION FILE | atnm-20240930_cal.xml | EX-101.CAL | 25472
9 | XBRL DEFINITION FILE | atnm-20240930_def.xml | EX-101.DEF | 147200
10 | XBRL LABEL FILE | atnm-20240930_lab.xml | EX-101.LAB | 305841
11 | XBRL PRESENTATION FILE | atnm-20240930_pre.xml | EX-101.PRE | 156416
52 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0217946-10q_actinium_htm.xml | XML | 304557

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 241463902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)